| Dr Carolyn M Terry, MD | |
|
12200 Preston Rd, Dallas, TX 75230-2223 | |
| (972) 560-2667 | |
| (972) 239-6649 |
| Full Name | Dr Carolyn M Terry |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 12200 Preston Rd, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629178595 | NPI | - | NPPES |
| 8M5533 | Other | TX | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | K6509 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carolyn M Terry, MD 12200 Preston Rd, Dallas, TX 75230-2223 Ph: (972) 560-2667 | Dr Carolyn M Terry, MD 12200 Preston Rd, Dallas, TX 75230-2223 Ph: (972) 560-2667 |
News Archive
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).
Women at high genetic risk of breast cancer could reduce their risk of developing the disease at an early age by taking oral contraceptives, a new study has found. The findings contradict previous studies, which suggested oral contraceptive use would increase the risk of developing breast cancer.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
To protect human health, Endocrine Society members called on the European Commission to adopt science-based policies for regulating endocrine-disrupting chemicals in an opinion piece published today in The Lancet Diabetes & Endocrinology.
› Verified 4 days ago
Tyler C Cooper, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12200 Preston Rd, Dallas, TX 75230 Phone: 972-560-2667 Fax: 972-239-6649 | |
Dr. Michele A Kettles, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12200 Preston Rd, Dallas, TX 75230 Phone: 972-560-2667 | |
Katharine H Smith, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3401 Lee Pkwy, #1702, Dallas, TX 75219 Phone: 214-507-8767 | |
Sofya Pugach, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 8989 Forest Ln Ste 146, Dallas, TX 75243 Phone: 972-792-7777 Fax: 972-792-7777 | |
Dr. Steven Michael Clark, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12200 Preston Rd, Dallas, TX 75230 Phone: 972-560-2667 | |
Dr. Lisa Marie Mcadams, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 Young St, Room 833, Dallas, TX 75202 Phone: 214-767-6456 Fax: 214-767-6454 | |
Dr. Riva L Rahl, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12200 Preston Rd, Dallas, TX 75230 Phone: 972-560-2667 |